Prevention of chronic diseases by tea: Possible mechanisms and human relevance

Annual Review of Nutrition

Volumn 33, Issue , 2013, Pages 161-181

  Yang, Chung S ^a   Hong, Jungil ^b  

^a RUTGERS UNIVERSITY   (United States)

^b Seoul Women University   (South Korea)

Author keywords

Cancer; Cardiovascular diseases; Diabetes; Polyphenols

Indexed keywords

ADIPONECTIN; CATECHIN; DRUG METABOLITE; GLUCOSE TRANSPORTER 4; GREEN TEA EXTRACT; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYPHENOL; PROANTHOCYANIDIN; THEAFLAVIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BODY WEIGHT; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC DISEASE; CLINICAL FEATURE; DEGENERATIVE DISEASE; DRUG BIOAVAILABILITY; DRUG TRANSFORMATION; HUMAN; HYDROGEN BOND; INSULIN SENSITIVITY; MAXIMUM PLASMA CONCENTRATION; METABOLIC SYNDROME X; NEUROPROTECTION; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; PROSTATIC INTRAEPITHELIAL NEOPLASIA; TEA; TREATMENT DURATION; WEIGHT CONTROL; WEIGHT REDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; FUNCTIONAL FOOD; HUMANS; METABOLIC SYNDROME X; NEOPLASMS; NERVOUS SYSTEM DISEASES; NUTRITIVE VALUE; OVERWEIGHT; TEA;

EID: 84880676216     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev-nutr-071811-150717     Document Type: Article

References (101)

1. Adhami VM, Siddiqui IA, AhmadN, Gupta S, Mukhtar H. 2004. Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mousemodel of prostate cancer. Cancer Res. 64:8715-22
2. Arab L, Biggs ML, O?Meara ES, Longstreth WT, Crane PK, Fitzpatrick AL. 2011. Gender differences in tea, coffee, and cognitive decline in the elderly: the Cardiovascular Health Study. J. Alzheimer?s Dis. 27:553-66
3. Arab L, Liu W, Elashoff D. 2009. Green and black tea consumption and risk of stroke: a meta-analysis. Stroke 40:1786-92
4. Arnaud MJ. 2011. Pharmacokinetics and metabolism of natural methylxanthines in animal and man. In Methylxanthines. Handbook of Experimental Pharmacology, Vol. 200, ed. BB Fredholm, pp. 33-91. Heidelberg, Berlin: Springer-Verlag
5. Balentine DA, Wiseman SA, Bouwens LC. 1997. The chemistry of tea flavonoids. Crit. Rev. Food Sci. Nutr. 37:693-704
6. Barranco Quintana JL, Allam MF, Del Castillo AS, Navajas RF. 2009. Parkinson?s disease and tea: a quantitative review. J. Am. Coll. Nutr. 28:1-6
7. Basu A, Du M, Sanchez K, Leyva MJ, Betts NM, et al. 2011. Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndrome. Nutrition 27:206-13
8. Basu A, Sanchez K, Leyva MJ, Wu M, Betts NM, et al. 2010. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J. Am. Coll. Nutr. 29:31-40
9. Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A. 2006. Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res. 66:1234-40
10. Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, et al. 2009. Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst. Rev. 3:CD005004
11. Bose M, Lambert JD, Ju J, Reuhl KR, Shapses SA, Yang CS. 2008. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J. Nutr. 138:1677-83
12. Brown AL, Lane J, Coverly J, Stocks J, Jackson S, et al. 2009. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3- gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br. J. Nutr. 101:886-94
13. Cao H, Hininger-Favier I, Kelly MA, Benaraba R, Dawson HD, et al. 2007. Green tea polyphenol extract regulates the expression of genes involved in glucose uptake and insulin signaling in rats fed a high fructose diet. J. Agric. Food Chem. 55:6372-78
14. Chang CS, Chang YF, Liu PY, Chen CY, Tsai YS, Wu CH. 2012. Smoking, habitual tea drinking and metabolic syndrome in elderly men living in rural community: the Tianliao Old People (TOP) study 02. PLoS ONE 7:e38874
15. ChangMC, Bailey JW, Collins JL. 1994. Dietary tannins from cowpeas and tea transiently alter apparent calcium absorption but not absorption and utilization of protein in rats. J. Nutr. 124:283-88
16. Chow HH, Cai Y, Hakim IA, Crowell JA, Shahi F, et al. 2003. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin. Cancer Res. 9:3312-19
17. Chow HH, Hakim IA. 2011. Pharmacokinetic and chemoprevention studies on tea in humans. Pharmacol. Res. 64:105-12
18. de Koning Gans JM, Uiterwaal CS, van der Schouw YT, Boer JM, Grobbee DE, et al. 2010. Tea and coffee consumption and cardiovascular morbidity and mortality. Arterioscler. Thromb. Vasc. Biol. 30:1665-71
19. Deka A, Vita JA. 2011. Tea and cardiovascular disease. Pharmacol. Res. 64:136-45
20. Devine A, Hodgson JM, Dick IM, Prince RL. 2007. Tea drinking is associated with benefits on bone density in older women. Am. J. Clin. Nutr. 86:1243-47
21. Di Castelnuovo A, di Giuseppe R, Iacoviello L, de Gaetano G. 2012. Consumption of cocoa, tea and coffee and risk of cardiovascular disease. Eur. J. Intern. Med. 23:15-25
22. Ellinger S, Muller N, Stehle P, Ulrich-Merzenich G. 2011. Consumption of green tea or green tea products: Is there an evidence for antioxidant effects from controlled interventional studies? Phytomedicine 18:903-15
23. Fang MZ, Wang Y, Ai N, Hou Z, Sun Y, et al. 2003. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res. 63:7563-70
24. Feng L, Gwee X, KuaEH, NgTP. 2010. Cognitive function and tea consumption in community dwelling older Chinese in Singapore. J. Nutr. Health Aging 14:433-8
25. Ford ES. 2005. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28:2745-9
26. Fukino Y, IkedaA, MaruyamaK, AokiN, Okubo T, Iso H. 2008. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur. J. Clin. Nutr. 62:953-60
27. Gao YT, McLaughlin JK, Blot WJ, Ji BT, Dai Q, Fraumeni JF Jr. 1994. Reduced risk of esophageal cancer associated with green tea consumption. J. Natl. Cancer Inst. 86:855-58
28. Guan F, Liu AB, Li G, Yang Z, Sun Y, et al. 2012. Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation. Nutr. Cancer 64:847-55
29. Gupta S, Hastak K, Ahmad N, Lewin JS, Mukhtar H. 2001. Inhibition of prostate carcinogenesis in TRAMP mice by oral infusion of green tea polyphenols. Proc. Natl. Acad. Sci. USA 98:10350-55
30. Hakim IA, Harris RB, Brown S, ChowHH, Wiseman S, et al. 2003. Effect of increased tea consumption on oxidative DNA damage among smokers: a randomized controlled study. J. Nutr. 133:3303-9S
31. Hara Y. 2011. Tea catechins and their applications as supplements and pharmaceutics. Pharmacol. Res. 64:100-4
32. Hegarty VM, May HM, Khaw KT. 2000. Tea drinking and bone mineral density in older women. Am. J. Clin. Nutr. 71:1003-7
33. Hintikka J, Tolmunen T, Honkalampi K, Haatainen K, Koivumaa-Honkanen H, et al. 2005. Daily tea drinking is associated with a low level of depressive symptoms in the Finnish general population. Eur. J. Epidemiol. 20:359-63
34. Hodgson JM, Puddey IB, Mori TA, Burke V, Baker RI, Beilin LJ. 2001. Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur. J. Clin. Nutr. 55:881-86
35. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, et al. 2008. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 88:38-50
36. Hozawa A, Kuriyama S, NakayaN, Ohmori-Matsuda K, KakizakiM, et al. 2009. Green tea consumption is associated with lower psychological distress in a general population: the Ohsaki Cohort 2006 Study. Am. J. Clin. Nutr. 90:1390-96
37. Hsu CH, Liao YL, Lin SC, Tsai TH, Huang CJ, Chou P. 2011. Does supplementation with green tea extract improve insulin resistance in obese type 2 diabetics? A randomized, double-blind, and placebocontrolled clinical trial. Altern. Med. Rev. 16:157-63
38. Hursel R, Viechtbauer W, Dulloo AG, Tremblay A, Tappy L, et al. 2011. The effects of catechin rich teas and caffeine on energy expenditure and fat oxidation: a meta-analysis. Obes. Rev. 12:e573-81
39. Hursel R, Viechtbauer W, Westerterp-PlantengaMS. 2009. The effects of green tea on weight loss and weight maintenance: a meta-analysis. Int. J. Obes. (Lond.) 33:956-61
40. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, et al. 2009. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus: a systematic review with metaanalysis. Arch. Intern. Med. 169:2053-63
41. Iso H, Date C, Wakai K, Fukui M, Tamakoshi A. 2006. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann. Intern. Med. 144:554-62
42. Jemnitz K, Heredi-Szabo K, Janossy J, Ioja E, Vereczkey L, Krajcsi P. 2010. ABCC2/Abcc2: a multispecific transporter with dominant excretory functions. Drug Metab. Rev. 42:402-36
43. Josic J, Olsson AT, Wickeberg J, Lindstedt S, Hlebowicz J. 2010. Does green tea affect postprandial glucose, insulin and satiety in healthy subjects: a randomized controlled trial. Nutr. J. 30:63
44. Ju J, Hong J, Zhou JN, Pan Z, Bose M, et al. 2005. Inhibition of intestinal tumorigenesis in ApcMin/+mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea. Cancer Res. 65:10623-31
45. Kakuda T. 2011. Neuroprotective effects of theanine and its preventive effects on cognitive dysfunction. Pharmacol. Res. 64:162-68
46. Koyama Y, Kuriyama S, Aida J, Sone T, Nakaya N, et al. 2010. Association between green tea consumption and tooth loss: cross-sectional results from the Ohsaki Cohort 2006 Study. Prev. Med. 50:173-79
47. Kuriyama S, Hozawa A, Ohmori K, Shimazu T, Matsui T, et al. 2006. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project 1. Am. J. Clin. Nutr. 83:355-61
48. KushiyamaM, Shimazaki Y, MurakamiM, Yamashita Y. 2009. Relationship between intake of green tea and periodontal disease. J. Periodontol. 80:372-77
49. Lee M-J, Maliakal P, Chen L, Meng X, Bondoc FY, et al. 2002. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomark. Prev. 11:1025-32
50. Lee W, Min WK, Chun S, Lee YW, Park H, et al. 2005. Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin. Biochem. 38:84-87
51. Li C, Lee MJ, Sheng S, Meng X, Prabhu S, et al. 2000. Structural identification of two metabolites of catechins and their kinetics in human urine and blood after tea ingestion. Chem. Res. Toxicol. 13:177-84
52. Li FJ, Ji HF, Shen L. 2012. A meta-analysis of tea drinking and risk of Parkinson?s disease. Sci. World J. 2012:923464
53. Li Y, Ying C, Zuo X, Yi H, Yi W, et al. 2009. Green tea polyphenols down-regulate caveolin-1 expression via ERK1/2 and p38MAPK in endothelial cells. J. Nutr. Biochem. 20:1021-27
54. Liang W, Lee AH, Binns CW, Huang R, Hu D, Zhou Q. 2009. Tea consumption and ischemic stroke risk: a case-control study in southern China. Stroke 40:2480-85
55. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. 2001. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 46:3-26
56. Lyon MR, Kapoor MP, Juneja LR. 2011. The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial. Altern. Med. Rev. 16:348-54
57. Mandel SA, Amit T, Kalfon L, Reznichenko L, YoudimMB. 2008. Targetingmultiple neurodegenerative diseases. Etiologies with multimodal-acting green tea catechins. J. Nutr. 138:1578-83S
58. Mazzanti G, Menniti-Ippolito F, Moro PA, Cassetti F, Raschetti R, et al. 2009. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur. J. Clin. Pharmacol. 65:331-41
59. Mehta SM, PritchardME, StegmanC. 1992. Contribution of coffee, and tea to anemia amongNHANES II participants. Nutr. Res. 12:209-22
60. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, et al. 2011. Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J. Epidemiol. Community Health 65:230-40
61. Mukamal KJ, Alert M, Maclure M, Muller JE, Mittleman MA. 2006. Tea consumption and infarctrelated ventricular arrhythmias: the Determinants of Myocardial Infarction Onset Study. J. Am. Coll. Nutr. 25:472-79
62. Ogunleye AA, Xue F, Michels KB. 2010. Green tea consumption and breast cancer risk or recurrence: a meta-analysis. Breast Cancer Res. Treat. 119:477-84
63. Papparella I, Ceolotto G, Montemurro D, Antonello M, Garbisa S, et al. 2008. Green tea attenuates angiotensin II-induced cardiac hypertrophy in rats by modulating reactive oxygen species production and the Src/epidermal growth factor receptor/Akt signaling pathway. J. Nutr. 138:1596-601
64. Park SK, Jung IC, Lee WK, Lee YS, Park HK, et al. 2011. A combination of green tea extract and L-theanine improves memory and attention in subjects with mild cognitive impairment: a double-blind placebo-controlled study. J. Med. Food 14:334-43
65. Peters U, PooleC, ArabL. 2001. Does tea affect cardiovascular disease?Ameta-analysis. Am. J. Epidemiol. 154:495-503
66. Phung OJ, Baker WL, Matthews LJ, Lanosa M, Thorne A, Coleman CI. 2010. Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am. J. Clin. Nutr. 91:73-81
67. PotenzaMA, Marasciulo FL, TarquinioM, Tiravanti E, Colantuono G, et al. 2007. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am. J. Physiol. Endocrinol. Metab. 292:E1378-87
68. Qin B, Polansky MM, Harry D, Anderson RA. 2010. Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Mol. Nutr. Food Res. 54(Suppl. 1):S14-23
69. Rains TM, Agarwal S, Maki KC. 2011. Antiobesity effects of green tea catechins: a mechanistic review. J. Nutr. Biochem. 22:1-7
70. Ritsner MS, Miodownik C, Ratner Y, Shleifer T, Mar M, et al. 2011. L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study. J. Clin. Psychiatry 72:34-42
71. Rogers JT, Randall JD, Cahill CM, Eder PS, Huang X, et al. 2002. An iron-responsive element type II in the 5?-untranslated region of the Alzheimer?s amyloid precursor protein transcript. J. Biol. Chem. 277:45518-28
72. Sae-tan S, Grove KA, Lambert JD. 2011. Weight control and prevention of metabolic syndrome by green tea. Pharmacol. Res. 64:146-54
73. Sang S, Lambert JD, Ho CT, Yang CS. 2011. The chemistry and biotransformation of tea constituents. Pharmacol. Res. 64:87-99
74. Sarma DN, Barrett ML, Chavez ML, Gardiner P, Ko R, et al. 2008. Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 31:469-84
75. Sasazuki S, Tamakoshi A, Matsuo K, Ito H, Wakai K, et al. 2012. Green tea consumption and gastric cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn. J. Clin. Oncol. 42:335-46
76. Serisier S, Leray V, Poudroux W, Magot T, Ouguerram K, Nguyen P. 2008. Effects of green tea on insulin sensitivity, lipid profile and expression of PPARalpha and PPARgamma and their target genes in obese dogs. Br. J. Nutr. 99:1208-16
77. Sesso HD, Gaziano JM, Liu S, Buring JE. 2003. Flavonoid intake and the risk of cardiovascular disease in women. Am. J. Clin. Nutr. 77:1400-8
78. Shen CL, Yeh JK, Cao JJ, Chyu MC, Wang JS. 2011. Green tea and bone health: evidence from laboratory studies. Pharmacol. Res. 64:155-61
79. Shen CL, Yeh JK, Cao JJ, Wang JS. 2009. Green tea and bone metabolism. Nutr. Res. 29:437-56
80. Shimizu M, Fukutomi Y, Ninomiya M, Nagura K, Kato T, et al. 2008. Green tea extracts for the prevention of metachronous colorectal adenomas: a pilot study. Cancer Epidemiol. Biomarkers Prev. 17:3020-25
81. Shimizu M, Shirakami Y, Sakai H, Adachi S, Hata K, et al. 2008. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev. Res. (Phila.) 1:298-304
82. Song Y, Manson JE, Buring JE, Sesso HD, Liu S. 2005. Associations of dietary flavonoids with risk of type 2 diabetes, and markers of insulin resistance and systemic inflammation in women: a prospective study and cross-sectional analysis. J. Am. Coll. Nutr. 24:376-84
83. Sturgeon JL, Williams M, van Servellen G. 2009. Efficacy of green tea in the prevention of cancers. Nurs. Health Sci. 11:436-46
84. Sun CL, Yuan JM, Koh WP, Lee HP, Yu MC. 2007. Green tea and black tea consumption in relation to colorectal cancer risk: the Singapore Chinese Health Study. Carcinogenesis 28:2143-48
85. SunCL, Yuan JM, KohWP, YuMC.2006. Green tea, black tea and colorectal cancer risk: ameta-analysis of epidemiologic studies. Carcinogenesis 27:1301-9
86. Tomata Y, KakizakiM, Nakaya N, Tsuboya T, Sone T, et al. 2012. Green tea consumption and the risk of incident functional disability in elderly Japanese: the Ohsaki Cohort 2006 Study. Am. J. Clin. Nutr. 95:732-39
87. Urusova DV, Shim JH, Kim DJ, Jung SK, Zykova TA, et al. 2011. Epigallocatechin-gallate suppresses tumorigenesis by directly targeting Pin1. Cancer Prev. Res. (Phila.) 4:1366-77
88. van der Pijl PC, Chen L, Mulder TPJ. 2010. Human disposition of L-theanine in tea or aqueous solution. J. Funct. Food 2:239-44
89. Vernarelli JA, Lambert JD. 2013. Tea consumption is inversely associated with weight status and other markers for metabolic syndrome in US adults. Eur. J. Nutr. 52:1039-48
90. Wang H, Wen Y, Du Y, Yan X, Guo H, et al. 2010. Effects of catechin enriched green tea on body composition. Obesity (Silver Spring) 18:773-79
91. Wang J, ZhangW, Sun L, Yu H, Ni QX, et al. 2012. Green tea drinking and risk of pancreatic cancer: a large-scale, population-based case-control study in urban Shanghai. Cancer Epidemiol. 36:e354-58
92. Wang ZM, Zhou B, Wang YS, Gong QY, Wang QM, et al. 2011. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am. J. Clin. Nutr. 93:506-15
93. Weinreb O, Amit T, Mandel S, Youdim MB. 2009. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: a reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr. 4:283-96
94. Yang CS, Sang S, Lambert JD, LeeMJ. 2008. Bioavailability issues in studying the health effects of plant polyphenolic compounds. Mol. Nutr. Food Res. 52(Suppl. 1):S139-51
95. Yang CS, Wang H, Li GX, Yang Z, Guan F, Jin H. 2011. Cancer prevention by tea: evidence from laboratory studies. Pharmacol. Res. 64:113-22
96. Yang CS, Wang X, Lu G, Picinich SC. 2009. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat. Rev. Cancer 9:429-39
97. Yang G, Shu XO, LiH, ChowWH, Ji BT, et al. 2007. Prospective cohort study of green tea consumption and colorectal cancer risk in women. Cancer Epidemiol. Biomarkers Prev. 16:1219-23
98. Yang G, Zheng W, Xiang YB, Gao J, Li HL, et al. 2011. Green tea consumption and colorectal cancer risk: a report from the Shanghai Men?s Health Study. Carcinogenesis 32:1684-88
99. Yuan JM, Gao YT, Yang CS, Yu MC. 2007. Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study. Int. J. Cancer 120:1344-50
100. Yuan JM, Sun C, Butler LM. 2011. Tea and cancer prevention: epidemiological studies. Pharmacol. Res. 64:123-35
101. Zang M, Xu S, Maitland-Toolan KA, Zuccollo A, Hou X, et al. 2006. Polyphenols stimulate AMPactivated protein kinase, lower lipids, and inhibit accelerated atherosclerosis in diabetic LDL receptordeficient mice. Diabetes 55:2180-91